OREANDA-NEWS. January 11, 2012. JSC "Grindeks" informs that the Supervisory Council has appointed Mr. Juris Bundulis as Chairman of the Board of JSC "Grindeks".

Mr. Kirovs Lipmans, the Chairman of the Council of JSC "Grindeks": „Appointing Juris Bundulis to position of the Chairman of the Board of "Grindeks", the Supervisory Council took into account his competency, experience and professionalism – he is knowledgeable in complex pharmaceutical manufacturing processes, in particularities of research projects, as well as in the business in general. I would like to emphasize that Latvia as the sales market is small for such a company as "Grindeks" – we are leading pharmaceutical company in Baltic’s with high international recognition and reputation. Our business activities and strategy have been export-oriented for long years. At present the products of the company are exported to 50 countries comprising 95% of the total turnover. For that reason, increase of the sales volumes in export markets, enlargement of product portfolio and enhancement of the competitiveness of company will be the main tasks for the new Chairman of the Board.”

Juris Bundulis has obtained the Doctoral degree in Biological Sciences in the University of Latvia; he has also graduated from the Faculty of Chemistry of the University of Latvia. Juris Bundulis has worked in "Grindeks" previously as the Marketing and Sales director and the Scientific Research and Development director. Prior his appointment as Chairman of the Board of "Grindeks" Juris Bundulis was the Deputy State Secretary of the Health Ministry of Latvia, where he worked on health politics issues.